EX9 Report

Exelixis, Inc.
Stock Exchange: XETRA
Sector: biotechnology
19.17
Last session price
19.17
Price now
Currency: EUR
Reporting currency: USD
ISIN: US30161Q1040
INN:
.

EX9 financial statements

* Numbers in millions
Year
 2020 TTM
Capitalization *
 5 684 5 801
EV *
 5 365 5 365
Stock price €
 18.786 19.17
Number of shares *
 303 303
EPS
 0,37 0,37
Revenue *
 988 988
Net income *
 112 112
Operating profit *
 110 110
Total liabilities *
 258 258
Net debt *
 -270 -270
Total assets *
 2 137 2 137
Equity *
 1 879 1 879
Cash and investments *
 1 207 1 207

Over the past 10 years, the maximum capitalization of Exelixis, Inc. is 5 684, the minimum is 5 684.
Maximum net income 112, Minimum net income 112.
The maximum price of EX9 shares is 18.786, the minimum price is 18.786.

.

EX9 valuation

Year
 2020 TTM
P/E
 50,85 51,89
P/B
 3,03 3,09
P/S
 5,76 5,87
E/P
 2% 2%
P/FCF
 31,82 32,47
.

EX9 profitability

Year
 2020 TTM
ROE
 6%
ROA
 5%
ROIC
 6%